Unraveling the Vaccination Gap: Addressing Disparities and Transparency in Israel’s Public Health Campaign

Neglected: Tens of thousands of reports of side effects from corona vaccine were ignored

The report by the Ministry of Health has brought attention to significant discrepancies in vaccination rates among different demographic groups in Israel. Initially, there was a sharp increase in the number of people receiving two doses of the vaccine. However, by the end of November 2022, the vaccination rate had moderated, with fewer people opting for the third dose compared to the initial two doses.

The audit also revealed shortcomings in the Ministry of Health’s computerized systems, which failed to capture critical information from a significant number of reports of side effects from the corona vaccine. This led to an incomplete investigation of side effects, with some cases not receiving the attention they warranted. Despite these challenges, the Ministry expressed pride in its vaccination campaign and efforts to protect public health.

However, it is important to note that while most reports received by the Ministry were regarding minor side effects such as chills and pain at the injection site, there were also more significant effects that warranted investigation. This included reports of menstrual disorders among women as well as reports of side effects among individuals over the age of 12 who received the vaccine. Notably, not all 33,000 reports received from the general public regarding side effects in 2021 were processed and analyzed by the Ministry.

In response to these findings, it is crucial that measures are taken to address any discrepancies in vaccination rates among different demographic groups and improve communication between healthcare providers and patients about potential side effects from vaccines.

Additionally, efforts should be made to ensure that all reports of side effects are thoroughly investigated and addressed promptly by healthcare providers.

Overall, it is essential that we continue to prioritize transparency and accountability in our approach to addressing any issues related to vaccines and public health.

Leave a Reply